This data set represents the best estimates of WHO using methodologies for specific indicators that aim for comparability across countries and time; they are updated as more recent or revised data become available, or when there are changes to the methodology being used. Therefore, they are not alwa...ys the same as official national estimates, although WHO whenever possible will provide Member States the opportunity to review and comment on data and estimates as part of country consultations. Note that these numbers are subject to change due to ongoing reclassification, retrospective investigation and availability of laboratory results. Please check the Indicator and Measurement Registry for indicator specific information.
In this section you will find data and statisticss:
Countries with intense transmission
Other affected countries
Download most recent available data
more
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are... disappearing, but other serogroups (e.g. NmW, NmX and NmC) still cause epidemics, albeit at a lower frequency and of a smaller size. Due to these changes, WHO organized the review of the evidence to provide recommendations for epidemic control, related to operational thresholds for investigation and response to outbreaks, the use of rapid diagnostic tests, antibiotic regimens in epidemics, and prophylaxis for household contacts of cases
more
This document provides guidelines on the establisment of early surveillance actions to be carried out in countries where no case of Ebola virus disease has been reported.
An alert system should be in place at the following sites: major land border crossing with already affected countries; capital ...cities, including at airports, seaports, and health-care facilities, especially in major hospitals.
The alert system (staff trained in case definitions and able to detect signs and symptoms of disease) should report sick persons coming from country that has reported cases of Ebola virus disease (EVD) and possibly meeting the definition of a case under investigation
more
This document provides interim recommendations for the surveillance of Zika virus infection, microcephaly and Guillain-Barré syndrome, in four different contexts and describes reporting requirements to WHO. Transmission refers to vector-borne transmission, unless specified differently. Autochthonou...s infection is considered to be an infection acquired in-country, i.e. among patients with no history of travel during the incubation period or who have travelled exclusively to non-affected areas during the incubation period. This document does not provide guidance on laboratory investigation or vector surveillance.
more
This Rapid Advice Guideline updates the Interim Guidance on the “Assessment of infants with microcephaly in the context of Zika virus” published in February 2016 (WHO/ZIKV/MOC/16.3). The recommendations provides guidance on the screening, clinical assessment, neuroimaging, laboratory investigati...on and follow-up of children born to women living in areas of Zika virus transmission. The Guideline summarises the evidence base and rationale in support of the recommendations and expands the scope to address complications beyond microcephaly and what is now referred to as the congenital Zika virus syndrome
more
This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy.
(Lecture series consist of a total of 59 cha...pters. Section one - introduction (chapter 1-2). Section two - basic science (chapters 3-5). Section (chapters 6-16). Section four - differential diagnosis (chapter 17-19). Section five - investigations (chapter 20-24). Section six - medical treatment of epilepsy (chapters 25-35). Section seven - outcome (chapters 36-40). Section eight - special groups (chapters 41-44). Section nine - surgical treatment of epilepsy (chapters 45-49). Section ten - social aspects (chapters 50-56). Section eleven - provision of care (chapters 57-59). All chapters available at: https://www.epilepsysociety.org.uk/lecture-notes-0#.Wq-cn8NubIU)
more
In 2016 WHO introduced the Cholera Kits. These kits replace the Interagency Diarrhoeal Disease Kit (IDDK) which had been used for many years. The Cholera Kit is designed to be flexible and adaptable for preparedness and outbreak response in different contexts. The overall Cholera Kit is made up of a...n Investigation Kit, Laboratory materials, 3 Treatment Kits (community, periphery and central) and a Hardware Kit. The Treatment and Hardware Kits are each composed of individual modules. Each of the kits and modules can be ordered independently based on field need. To support orders, a Cholera Kit Calculation Tool was developed.
The information note, packing lists and the Kit Calculation Tool are all available from the WHO website at: http://www.who.int/cholera/kit/en/
more
El documento ayudará a los países a identificar las áreas de necesidades y determinar cómo se puede reforzar la red de entomología, especialmente en el contexto de un sistema de salud descentralizado. Las recomendaciones también tienen en cuenta los diferentes grados de desarrollo y las difere...ntes investigaciones entomológicas necesarias para dar soporte a las acciones de prevención y control de las enfermedades.
more
Child Friendly Spaces (CFSs) are used by humanitarian agencies as a means to promote protection and psychosocial wellbeing for children in emergency settings. World Vision International together with Columbia University is conducting a series of studies to investigate the effectiveness of CFSs in va...rious humanitarian contexts in order to document evidence of the positive effects they have in relation to child wellbeing and protection, to identify good practice in their design and implementation and to develop improved monitoring and evaluation approaches for CFSs. The case studies have so far all been focused on refugee settings and while internally displaced populations (IDPs) share many of the circumstances and challenges of refugees it was decided that CFSs operating in IDP settings warrant a particular investigation in order to assess their relevance and effectiveness in promoting child protection and psychosocial wellbeing. This report thus presents the findings from an IDP focused study on CFS effectiveness in three camps near Goma, eastern Democratic Republic of Congo (DRC).
more
This technical guidance outlines current evidence, knowledge and best practice relating to incidences of violence and injuries among refugees and migrants in the WHO European Region. It highlights key principles, summarizes priority actions and challenges, maps existing international commitments and... frameworks and provides practical policy considerations for preventing and responding to such challenges. Specific areas for intervention include ensuring safe passage for migration; addressing causes of violence and injuries in transit and destination countries, including changing norms and values; identifying victims and providing care and protection; investigating and prosecuting perpetrators; and strengthening the knowledge base. While the main intended audience of this technical guidance series are policy-makers across sectors at local, national and regional levels, the contents of this publication will also be of value for health-care practitioners and law enforcement and border protection officials.
more
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...method, nucleic acid amplification tests (NAATs). This interim guidance offers recommendations on the priority uses of antigen-detecting rapid diagnostic tests (Ag-RDTs) in specific populations and settings, including (i) for primary case detection in symptomatic individuals suspected to be infected and asymptomatic individuals at high risk of COVID-19, (ii) for contact tracing, (iii) during outbreak investigations and (iv) to monitor trends of disease incidence in communities. Ag-RDTs meeting minimum performance requirements can be used outside of clinical and laboratory settings, including in communities, by trained operators in accordance with instructions. The guidance additionally provides recommendations on implementation, product selection and storage.
more
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...h technologies to use and/or in deciding on the role of sequencing for SARS-CoV-2 diagnostics, research, outbreak investigations and surveillance. It addresses the most used sequencing technologies and their applications and proposes a central standardisation process to analyse and report the findings of SARS-CoV-2 genetic characterisations.
more
Latest update: 29 De 2021. Slideset updated regularly to include the latest data and guidance on non-therapeutic and therapeutic treatments for COVID-19, including authorized and investigational agents.
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and analyzed in the laboratory of Instituto Nacional de In...vestigación en Salud Pública Guayaquil. The analysis of the results of GeneXpert in comparison with smear microscopy showed an initial sensitivity of 99.8% and specificity of 93.2%; The analysis of discrepancies using the results of the culture as a reference method showed that the GeneXpert results considered false negatives turned out to be true negatives, the same happens with the false positives that correspond to true positives. Recalculated the sensitivity and specificity of the GeneXpert was 99.8% and 100% correspondingly. The comparison with the drugs susceptibility test showed a sensitivity of 91.4% and a specificity of 95.5% for the GeneXpert MTB/RIF system. It is concluded that the implementation of the GeneXpert system allows solution to certain problems associated with the application of conventional diagnostic methodologies, decreasing the waiting times, and increasing the sensitivity and specificity in the diagnosis of drug-resistant tuberculosis, thus generating a valuable opportunity for early diagnosis.
more
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize ...the efficiency of assessment, review and authorizations of medical products. Vaccines are undoubtedly the most complex medical products to develop, from concept to a stage where sufficient evidence of quality, safety and efficacy are collected to provide an assurance that their use will provide more benefits than risks when used in the context of a public health emergency.
more
Los Módulos de autoaprendizaje sobre tuberculosis son una serie de módulos educativos diseñados para proporcionar información sobre la tuberculosis en un formato de autoaprendizaje. El módulo 6 (“Manejo de pacientes con tuberculosis y mejora de la adherencia al tratamiento”) y el módulo 8 ...(“Investigaciones de contactos de tuberculosis”) están disponibles en español. Los módulos 1-9 están disponibles en inglés.
more
La tesis titula “Nivel de conocimiento sobre tuberculosis pulmonar de los pobladores que acuden al Centro de Salud Juan Parra del Riego El Tambo, 2019”, esta investigación tuvo como objetivo: Determinar el nivel de conocimiento sobre tuberculosis pulmonar de los pobladores que acuden al Centro ...de Salud Juan Parra del Riego. La metodología: la investigación es tipo descriptiva, observacional y transversal, la muestra fue de 80 personas mayores de edad que acudieron al establecimiento de salud.
more
Este documento presenta las principales conclusiones alcanzada durante la jornada El suicidio adolescente en la Argentina: recomendaciones de política pública.
En el encuentro un grupo de expertas y expertos, a partir de la evidencia obtenida en la investigación presentada por UNICEF y sus exper...iencias y conocimientos, dialogaron sobre los principales cuellos de botella en la implementación de acciones de prevención, atención, posvención y registro en el abordaje del suicidio adolescente, así como también sobre las estrategias de intervención priorizadas para su superación.
La metodología utilizada en la jornada se desprende del Sistema de Monitoreo de Resultados para la Equidad (MoRES, por sus siglas en inglés) como parte del enfoque en la equidad desarrollado por UNICEF.
more
Somos una asociación científica que reúne a los profesionales relacionados con la prevención, manejo, control, educación e investigación de las enfermedades infecciosas. Contribuimos con las entidades de salud, gubernamentales y educativas, en la creación e implementación de políticas nacio...nales y regionales en el manejo de las enfermedades infecciosas. Propendemos por el bienestar de nuestros asociados.
more
Accessed on 10.09.2022
Para evaluar la situación basal de los PROA en Chile, el grupo iniciativa del Milenio para la Investigación Colaborativa en Resistencia Bacteriana (MICROB-R), realizó una encuesta que en colaboración con el Ministerio de Salud debía ser respondida por los hospitales p...blicos y privados de mediana y alta complejidad, durante el año 2021. Cabe señalar que debido a la contingencia de la pandemia por COVID-19, la llegada de la información y el monitoreo adecuado de las respuesta a la encuesta
por parte de las SEREMIs y Servicios de Salud se hizo muy dificultosa, lográndose que sólo un 56% de los hospitales respondieran la encuesta.
El presente informe da cuenta de los resultados obtenidos en la encuesta realizada.
more